Two Sigma Investments’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.06M | Sell |
749,660
-70,604
| -9% | -$100K | ﹤0.01% | 2161 |
|
|
2025
Q1 | $1.26M | Sell |
820,264
-19,006
| -2% | -$29.1K | ﹤0.01% | 1995 |
|
|
2024
Q4 | $2.08M | Sell |
839,270
-68,646
| -8% | -$170K | ﹤0.01% | 1622 |
|
|
2024
Q3 | $1.04M | Sell |
907,916
-205,156
| -18% | -$236K | ﹤0.01% | 2036 |
|
|
2024
Q2 | $1.22M | Sell |
1,113,072
-216,544
| -16% | -$238K | ﹤0.01% | 1811 |
|
|
2024
Q1 | $1.65M | Sell |
1,329,616
-133,845
| -9% | -$166K | ﹤0.01% | 1558 |
|
|
2023
Q4 | $1.54M | Buy |
1,463,461
+1,437,561
| +5,550% | +$1.51M | ﹤0.01% | 1724 |
|
|
2023
Q3 | $177K | Buy |
+25,900
| New | +$177K | ﹤0.01% | 2585 |
|
|
2023
Q2 | – | Sell |
-84,442
| Closed | -$683K | – | 2893 |
|
|
2023
Q1 | $683K | Buy |
84,442
+73,742
| +689% | +$597K | ﹤0.01% | 1989 |
|
|
2022
Q4 | $169K | Buy |
+10,700
| New | +$169K | ﹤0.01% | 2365 |
|
|
2022
Q1 | – | Sell |
-13,044
| Closed | -$190K | – | 2505 |
|
|
2021
Q4 | $190K | Sell |
13,044
-96,784
| -88% | -$1.41M | ﹤0.01% | 2311 |
|
|
2021
Q3 | $1.98M | Sell |
109,828
-265,474
| -71% | -$4.78M | ﹤0.01% | 1372 |
|
|
2021
Q2 | $6.59M | Buy |
375,302
+201,226
| +116% | +$3.53M | 0.01% | 798 |
|
|
2021
Q1 | $4.39M | Buy |
174,076
+87,984
| +102% | +$2.22M | 0.01% | 899 |
|
|
2020
Q4 | $557K | Buy |
+86,092
| New | +$557K | ﹤0.01% | 1556 |
|
|
2019
Q3 | – | Sell |
-71,581
| Closed | -$157K | – | 1908 |
|
|
2019
Q2 | $157K | Sell |
71,581
-92,116
| -56% | -$202K | ﹤0.01% | 1889 |
|
|
2019
Q1 | $981K | Buy |
163,697
+58,368
| +55% | +$350K | ﹤0.01% | 1436 |
|
|
2018
Q4 | $778K | Buy |
+105,329
| New | +$778K | ﹤0.01% | 1420 |
|